Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoledronic Acid for Fracture Prevention After Hip Fracture
NCT00046254Phase 3Completed
- Sponsor
- Novartis
- Start
- Feb 2002
- Primary completion
- Feb 2007
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of zoledronic acid in osteoporosis, sponsored by Novartis. Started Feb 2002; status: completed.
02
Drugs
zoledronic acid
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT00046254.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00046254.